Although there are advancements in the field of breast cancer screening, diagnosis, and treatment, about 12% of these patients globally eventually develop metastatic breast cancer; the 5-year survival rate of metastatic breast cancer is just 26%.1 A plethora of newer approved treatment regimens a
ASCO updated guidelines
biomarkers
metastatic breast cancer
Login
To get access to full MedEnrich experience, please Sign in